Background: Neuropathic pain with complicated mechanism severely disrupts patient quality of life. The novel approaches and more effective management should be further investigated. It was reported that alpha-7 nicotinic acetylcholine receptor (α7nAChR) and janus kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) signaling in dorsal root ganglion (DRG) contributed to the pathogenesis of neuropathic pain. Our previous study has shown that electroacupuncture (EA) alleviated neuropathic pain via activating α7nAChR in the spinal cord. However, whether the effect of 2 Hz EA on spared nerve injury (SNI)-induced neuropathic pain is mediated through modulation of α7nAChR and JAK2/STAT3 pathway in the DRG remains unclear. Materials and methods: The SNI-induced neuropathic pain rat model was used in this study. After application of 2 Hz EA treatment to SNI rats on day 3, 7, 14 and 21 post-surgery, the expression levels of α7nAChR, JAK2/STAT3 and some cytokines in DRG were determined by qRT-PCR and Western blot analysis. Results: We found that SNI induced significant down-regulation of α7nAChR mRNA and protein expression. SNI also obviously elicited the decrease in anti-inflammatory cytokine IL-10 protein expression. The enhancement of p-JAK2, p-STAT3, pro-inflammatory cytokines IL-1β and IL-6 protein levels induced by SNI were also observed. However, 2 Hz EA treatment to SNI rats distinctly improved α7nAChR and IL-10 levels and reduced p-JAK2, p-STAT3, IL-1β and IL-6 expression in the DRG. Conclusion: Our present study suggested that 2 Hz EA treatment indeed activated α7nAChR, suppressed JAK2/STAT3 signaling and re-balanced the relationship between pro-inflammatory and anti-inflammatory cytokines in DRG of SNI rat, which provided insight into our understanding of the mechanism for 2 Hz EA to attenuate neuropathic pain.
Introduction
Neuropathic pain is a complex chronic condition resulting from peripheral nerve injury. Evidence shows a role of neuro-inflammation in the pathogenesis of neuropathic pain. 1 The pro-inflammatory cytokines such as IL-1β, IL-6 and TNF-α participate in the initiation and maintenance of neuropathic pain. 2 In contrast, IL-10, a powerful anti-inflammatory cytokine, exerts its anti-inflammatory effects in neuropathic pain. These findings revealed that an imbalance between the proinflammatory and anti-inflammatory cytokines mediated the modulation of neuropathic pain. [3] [4] [5] Currently, cholinergic anti-inflammatory pathway may provide a new attempt to explore novel treatments against neuropathic pain. The cholinergic anti-inflammatory pathway modulates the nervous systems via acetylcholine (ACh) acting on the alpha-7 nicotinic acetylcholine receptor (α7nAChR, encoded by the cholinergic receptor nicotinic alpha 7 subunit [CHRNA7] gene). 6 α7nAChR was revealed to modulate chronic pain and be widely distributed in spinal cord and dorsal root ganglion (DRG). 7, 8 The down-regulation of α7nAChR expression in DRG was observed in chronic constriction injury (CCI)-induced neuropathic pain rats. 9, 10 Activation of α7nAChR attenuates neuropathic pain via reducing the production of proinflammatory cytokines IL-1β, IL-6, and TNF-α and increasing the anti-inflammatory cytokine IL-10. [11] [12] [13] Our previous results also confirmed the down-regulation of spinal α7nAChR expression level in spared nerve injury (SNI) rats, 14 indicating that α7nAChR played a key role in the modulation of neuropathic pain. Accumulating studies showed that α7nAChR inhibited its downstream molecules janus kinase 2 (JAK2, encoded by the Janus kinase 2 [Jak2] gene)/signal transducer and activator of transcription 3 (STAT3, encoded by the signal transducer and activator of transcription 3 [Stat3] gene) phosphorylation and pro-inflammatory cytokines IL-1β, IL-6 and TNF-α release. 12, 13, 15 The activation of JAK2/STAT3-signalinginduced-neuropathic pain was attenuated by intrathecal injection of JAK2/STAT3 inhibitor. [16] [17] [18] Collectively, the data indicated that the suppression of JAK/STAT3 signaling via activating α7nAChR implicated in controlling neuropathic pain. It is reported that neuropathic pain involves some pathophysiological alterations that occur within the peripheral and CNS. 19 The DRG is well known to be a critical position for integration and transmission of nociceptive signaling from the peripheral nerve to CNS. 20 The injury site in DRG leads to peripheral and central sensitization and then elicits neuropathic pain. 21, 22 The results demonstrated that DRG plays a pivotal role in the transmission and modulation of chronic pain. The mechanism underlying neuropathic pain is complicated and it has ineffective treatment. 23, 24 Thus, neuropathic pain remains a major public health problem that affects millions of individuals. 25 Electroacupuncture (EA) has been identified as an effective management for neuropathic pain. 26, 27 Our recent study has revealed that 2 Hz EA could alleviate SNI-induced neuropathic pain via activating α7nAChR in the spinal cord. 14 The α7nAChR was reported to be associated with JAK2/STAT3 signaling to participate in modulating neuropathic pain. 13 Moreover, EA treatment was shown to attenuate visceral hypersensitivity through inhibiting spinal JAK2/STAT3 signaling. 28 Taken together, the activation of α7nAChR or JAK2/ STAT3 signaling in spinal cord may mediate EA stimulation suppressing pain hypersensitivity. However, no corresponding report has been found in DRG. Based on these previous results, we focus on investigating whether α7nAChR and JAK2/STAT3 signaling in DRG mediates the effect of 2 Hz EA on SNI-evoked neuropathic pain.
In this experiment, we aim to explore the effect of 2 Hz EA on the expression levels of α7nAChR and JAK2/ STAT3 signaling in DRG of SNI rat. Additionally, we further assess the effect of 2 Hz EA treatment on the relationship between pro-inflammatory cytokines IL-1β, IL-6 and anti-inflammatory cytokine IL-10. Findings from this study may provide evidence that α7nAChR and JAK2/STAT3 signaling pathway in DRG serves as new targets for 2 Hz EA treatment to neuropathic pain.
Materials and methods

Experimental animals
Healthy adult male Sprague-Dawley (SD) rats weighing 160-180 g (seven to eight weeks old) were obtained from Hunan SLAC Laboratory Animal Co., Ltd. (Changsha, China). The rats were housed five per cage with free access to food and water, and they were kept at a temperature-controlled (22-24°C) room and under a 12/12 hrs light/dark cycle. The rats were acclimatized to the surrounding for 5 days before the initiation of study. This experiment was performed in a quiet environment and conducted in a double-blind way. Rats were randomly divided into three groups of sham, SNI and SNI+EA. All animal experimental procedures were approved by the Animal Use and Protection Committee of Gannan Medical University in China and carried out in accordance with the guidelines of the International Association for the Study of Pain. A total of 70 rats were used in this study.
Electroacupuncture stimulation
Rats were restrained in specially designed holders with their hind legs and tails exposed as described in our previous studies. 14, 29 Briefly, the skin of rat hind legs was sterilized with 75% alcohol. Two stainless-steel needles (4 mm length, 0.4 mm diameter) were inserted into each leg of rat. One needle was inserted at the Zusanli acupoint (ST36), which was 5 mm lateral to the anterior tubercle of the tibia marked by a notch, and the other needle was inserted at the Sanyinjiao acupoint (SP6), which was 3 mm proximal to the medial malleolus and at the posterior border of the tibia. The stimulation square waves of EA generated from a Han's Acupoint Nerve Stimulator (HANS, LH202, Beijing Huawei Industrial Developing Company, China) were applied to both legs of rat simultaneously. Rats received EA stimulation for 30 mins once every other day lasting for 21 days. The EA stimulation frequency was an application of 2 Hz with pulse width of 0.6 ms, and the stimulation intensity was increased in a stepwise way at 1-2-3 mA, each intensity lasting for 10 mins. Rats were always kept awaken in the process of EA treatment.
Establishment of spared nerve injury model
Following a five day surrounding adaptation, the SNIinduced neuropathic pain rat model was established according to the method described by Decosterd and Woolf. 30 Briefly, rats were anesthetized by 2-3% isoflurane, and then exposing the left lateral sciatic nerve and its three terminal branches (the sural, common peroneal and tibial nerves). The left lateral common peroneal and the tibial nerves were tight-ligated with 5-0 silk suture and sectioned distal to the ligation, removing 2-4 mm of the distal nerve stump, and leaving the sural nerve intact. Muscle and skin were closed in two layers under sterile operation. Only rats that developed mechanical hypersensitivity were used in the study. The mechanical hypersensitivity was examined by PWT as described in previous study. 14 Sham-surgery rats underwent all identical surgical procedures except that the tibial and common peroneal nerves were left intact.
Quantitative RT-PCR analysis
The mRNA expression of α7nAChR was detected by quantitative reverse transcription and real-time polymerase chain reaction (qRT-PCR). Under deep anesthesia with 2-3% isoflurane, the fresh L4-L6 segments DRG of rat were rapidly collected in 1.5 ml centrifuge tube and stored in liquid nitrogen. Total RNA was isolated from the L4-L6 segments DRG and prepared for qRT-PCR as described in previous report. 31 The primer sequences for qRT-PCR were provided by Invitrogen (USA), the primer sequences used in this experiment were as the follows: α7nAChR, sense CCCTGGCTCTGCTGGTATTC, antisense TGGTG CTGGCGAAGTATTGT; GAPDH, sense CAGCCGCATC TTCTTGTGC, antisense GGTAACCAGGCGTCCGATA. Quantitative RT-PCR data were normalized with GAPDH mRNA level which was used as a control, and relative mRNA level was expressed as 2-ΔΔCt values.
Western blot analysis
Following deep anesthesia with 2-3% isoflurane, the DRG of rat was dissected and isolated immediately and rinsed in ice-cold PBS. The grounded L4-L6 segments DRG were rapidly removed for the extraction of protein. This procedure was performed as described in previous study. 31 Thirty micrograms of protein per sample were denatured and then separated with 10% SDS-PAGE and western-blotted on a PVDF (Millipore, CA) membrane using a minigel and mini transblot apparatus (Bio-Rad, Hercules, CA). The membrane was blocked with 5% non-fat milk in Tris-buffered saline containing 0.1% Tween-20 for 60 mins at room temperature, and subsequently the membrane respectively immuno-labelled overnight at 4°C with antibodies of rabbit anti-α7nAChR ( 
Statistical analysis
Statistical analyses were performed using Prism 5.0 software. All experimental data were expressed as the mean ± SEM. The data differences between groups were analyzed using one-way ANOVA followed by Newman-Keuls post-hoc tests. P<0.05 was considered to represent statistically significant. Samples were collected from the L4-L6 segment of DRG on day 3, 7, 14 and 21 after surgery. *P<0.05, **P<0.01, ***P<0.001, compared with Sham group, # P<0.05, ## P<0.01, ### P<0.001, compared with SNI group. All data were expressed as the mean ± SEM, n=4-6 per group. One-way ANOVA followed by Newman-Keuls post-hoc test.
Abbreviations: EA, electroacupuncture; SNI, spared nerve injury; IL-1β, Interfenon-1beta; IL-6, Interfenon-6; DRG, dorsal root ganglion; d, day; SEM, standard error of the mean.
P<0.001) on day 3, 7, 14 and 21, respectively ( Figure 3C and D). The finding showed that 2 Hz EA suppressed proinflammatory cytokines IL-1β and IL-6 expression which was induced by nerve injury in DRG.
Effect of 2 Hz EA on anti-inflammatory cytokine IL-10 protein expression in DRG After rats were given 2 Hz EA treatment, the anti-inflammatory cytokine IL-10 protein expression in DRG was determined on day 3, 7, 14 and 21 post-surgery. As shown in Figure 4 , IL-10 protein expression in the SNI group was significantly decreased compared to the sham group (P<0.05, P<0.01) on day 3, 7, 14 and 21, respectively. However, in comparison with the SNI group, IL-10 protein expression in the SNI+EA group was significantly enhanced (P<0.01, P<0.001) on day 3, 7, 14 and 21, respectively, which indicated that 2 Hz EA treatment exerted an anti-neuroinflammation effect through the upregulation of anti-inflammatory cytokine IL-10 protein expression in DRG.
Discussion
The mechanism underlying neuropathic pain induced by peripheral nerve injury is extremely complex, and has no effective management. Our previous results have revealed that the activation of α7nAChR in spinal cord mediated 2 Hz EA alleviating mechanical hypersensitivity induced by neuropathic pain.
14 DRG is indicated to be a pivotal region for detecting, processing and conveying primary sensory information such as painful stimuli to CNS. [20] [21] [22] Based on these data, we have focused on investigating the effect of α7nAChR and JAK2/STAT3 signaling on 2 Hz EA relieving SNI-induced neuropathic pain in the DRG. This present study showed that SNI elicited the down-regulation of α7nAChR and anti-inflammatory cytokine IL-10 expression, as well as the enhancement of JAK2/STAT3, proinflammatory cytokines IL-1β and IL-6 levels in the DRG. Meanwhile, 2 Hz EA treatment significantly increased α7nAChR and IL-10 and reduced the expression of JAK2/STAT3, IL-1β and IL-6 in DRG of SNI rats.
Finding from this study provided novel insight into understanding the molecular mechanism underlying 2 Hz EA ameliorating SNI-induced neuropathic pain. Cholinergic anti-inflammatory pathway provides a novel strategy against chronic pain and modulates the immune and nervous systems through α7nAChR activation. 32 The α7nAChR was displayed to mainly express on pain transmission pathways such as spinal cord and DRG, and mediated anti-inflammatory effects via down-regulating pro-inflammatory cytokines. 32, 33 Similarly, our previous experiment has shown that α7nAChR mRNA and protein expression were markedly decreased in the spinal cord of SNI rats. 14 In this study, we also found that SNI elicited significant down-regulation of α7nAChR mRNA and protein expression in the DRG. Collectively, the results suggested that α7nAChR has taken part in modulating neuropathic pain in the spinal cord and DRG. Neuropathic pain greatly disrupts patient quality of life and leads to a wide variety of problems worldwide. However, there are some limitations in the current pharmacological treatment for neuropathic pain. Therefore, another management for neuropathic pain should be taken into consideration. EA stimulation with few side effects has possessed action to alleviate chronic pain. 34, 35 Evidence also showed that EA treatment distinctly ameliorated mechanical hypersensitivity evoked by neuropathic pain. 22, 29, 34, 36 2 Hz EA-induced analgesic effect to neuropathic pain was better than 100 Hz EA did, 35 and the application of 2 Hz EA for once every other day produced the better cumulative analgesic effect. 37 Thus, here 2 Hz EA stimulation was selected to treat the SNI-induced neuropathic pain as described in our previous study. 14 Our recent study has indicated that 2 Hz EA could attenuate mechanical hypersensitivity and increase spinal α7nAChR mRNA and protein expression in SNI rats. In addition, immunofluorescence staining also revealed that 2 Hz EA treatment up-regulated α7nAChR expression in the spinal cord of SNI rats.
14 However, whether involvement of α7nAChR in 2 Hz EA alleviating SNI-induced neuropathic pain in DRG remains poorly understood. In agreement with our previous studies, the up-regulation of α7nAChR evoked by 2 Hz EA treatment to SNI rats was also observed in the DRG, which suggested that α7nAChR in DRG also implicated in 2 Hz EA-induced analgesia in SNI rats. The formation of neuropathic pain involved various cellular transduction of signaling pathways, such as JAK2/STAT3 signaling which was one of the most important cascades, in response to both pro-inflammatory (IL-1β, IL-6 and TNF-α) and anti-inflammatory (IL-10) cytokines. 38 The JAK/STAT3 signaling was mainly expressed in the spinal cord and DRG. 17 The up-regulation of JAK/STAT3 expression was also found in neuropathic pain. 3 The studies indicated that the JAK/STAT3 signaling pathway contributed to the genesis of neuropathic pain.
Our present results displayed that SNI induced the enhancement of p-JAK2 and p-STAT3 expression levels in the DRG, which implied that JAK2/STAT3 signaling in DRG may be involved in the modulation of SNI-induced neuropathic pain. Our further investigation revealed that 2 Hz EA treatment could inhibit the phosphorylation of JAK2 and STAT3 in DRG of SNI rats, suggesting that 2 Hz EA relieved SNI-evoked neuropathic pain maybe via suppression of JAK2/STAT3 signaling in the DRG. Neuro-immune interaction may be crucial for controlling chronic pain. 39 Several inflammatory mediators participated in the neuro-immune response. Among them, the pro-inflammatory cytokines play critical role in the neuro-immune response induced by SNI. 4 The release of pro-inflammatory cytokines and the loss of anti-inflammatory cytokines contributed to the process of pain sensitization. 4 Indicating that an imbalance in the cytokine micro-environment mediated the modulation of neuropathic pain. 3, 5 Some pro-inflammatory cytokines such as IL-1β, IL-6 and TNF-α were showed to implicate in the genesis of neuropathic pain. 34 Conversely, IL-10 was regarded as a powerful anti-inflammatory cytokine which exerted its anti-inflammatory effects in neuropathic pain. Such as repeated intrathecal injections of IL-10 could reverse mechanical hypersensitivity induced by neuropathic pain, 40 IL-10 obviously reduced the inflammatory response via suppressing pro-inflammatory cytokines (IL-1β, IL-6 and TNF-α) at the site of nerve injury, IL-10 protein expression in DRG was significantly down-regulated in lumbar ventral root transection and CCI-induced neuropathic pain. 41, 42 Consistently, our present data revealed that SNI distinctly induced the up-regulation of IL-1β and IL-6 protein expression in the DRG, and along with the significant down-regulation of IL-10 level, which suggested that the imbalance between pro-inflammatory cytokines IL-1β, IL-6 and anti-inflammatory cytokine IL-10 in DRG contributed to SNI-induced neuropathic pain. Based on the relationship between pro-inflammatory and anti-inflammatory cytokines in SNI-evoked neuropathic pain, our further study was required to elucidate the mechanism for 2 Hz EA attenuating neuropathic pain in DRG. Presently, we found that 2 Hz EA treatment markedly suppressed the up-regulation of pro-inflammatory cytokines (IL-1β and IL-6) expression and the down-regulation of anti-inflammatory cytokine (IL-10) level elicited by SNI in DRG. Thus, 2 Hz EA alleviated SNI-induced neuropathic pain maybe via re-balancing the cytokines micro-environment in the DRG.
There are some limitations in this study. First, the SNI rat model being used in this experiment elicited distinct phenotypic variations, but which did not represent all neuropathic pain conditions. Second, based on our previous studies, the activation of α7nAChR, suppression of JAK2/STAT3 signaling and re-balance in cytokines microenvironment by 2 Hz EA were taken into consideration in this study, but there was no further investigation for the link between the alterations of α7nAChR, JAK2/STAT3 and some cytokines protein expression and the analgesic effect of 2 Hz EA with inhibitors or antagonists.
Conclusion
The present study suggested that 2 Hz EA treatment activated α7nAChR, suppressed JAK2/STAT3 signaling and re-balanced the cytokines micro-environment relationship between pro-inflammatory cytokines (IL-1β and IL-6) and anti-inflammatory cytokine (IL-10) in DRG of SNI rat, which provided evidence that α7nAChR and JAK2/ STAT3 signaling may be potential therapeutic targets for 2 Hz EA treatment to neuropathic pain.
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